Bharat B. Aggarwal
Impact in
- Molecular Medicine top 0.01%
- Curcumin's Biomedical Applications
- Toxicology top 0.01%
Papers in
-
- Natural product bioactivities and synthesis 88
- Genomics, phytochemicals, and oxidative stress 36
- Retinoids in leukemia and cellular processes 35
- Cancer Research 181
- NF-κB Signaling Pathways 164
- Co-authors
- Ajaikumar B. Kunnumakkara (60 shared papers)Subash C. Gupta (51 shared papers)Shishir Shishodia (48 shared papers)Bokyung Sung (85 shared papers)Preetha Anand (12 shared papers)Sahdeo Prasad (48 shared papers)Gautam Sethi (57 shared papers)Kuzhuvelil B. Harikumar (18 shared papers)
- Journals
- Journal of Biological Chemistry (57 papers)The Journal of Immunology (34 papers)Biochemical Pharmacology (23 papers)Cancer Research (19 papers)Blood (17 papers)
- Partner nations
- United StatesIndiaGermany
In The Last Decade
Bharat B. Aggarwal
566 papers receiving 102.1k citations
Bharat B. Aggarwal's Hit Papers
Peers
Comparison fields: 5 of 210
- Molecular Medicine 25.4k
- Toxicology 3.7k
- Geriatrics and Gerontology 3.0k
- Cancer Research 13.2k
- Biochemistry 5.4k
Countries citing papers authored by Bharat B. Aggarwal
This map shows the geographic impact of Bharat B. Aggarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bharat B. Aggarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bharat B. Aggarwal more than expected).
Fields of papers citing papers by Bharat B. Aggarwal
This network shows the impact of papers produced by Bharat B. Aggarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bharat B. Aggarwal. The network helps show where Bharat B. Aggarwal may publish in the future.
Co-authors
The 25 scholars most cited alongside Bharat B. Aggarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 574 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bioavailability of Curcumin: Problems and Promises Hit paper breakdown → | 2007 | 4518 |
| 2 | Oxidative stress, inflammation, and cancer: How are they linked? Hit paper breakdown → | 2010 | 4269 |
| 3 | Signalling pathways of the TNF superfamily: a double-edged sword Hit paper breakdown → | 2003 | 2190 |
| 4 | Anticancer potential of curcumin: preclinical and clinical studies. Hit paper breakdown → | 2003 | 2177 |
| 5 | Curcumin as “Curecumin”: From kitchen to clinic Hit paper breakdown → | 2007 | 1809 |
| 6 | Cancer is a Preventable Disease that Requires Major Lifestyle Changes Hit paper breakdown → | 2008 | 1624 |
| 7 | Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases Hit paper breakdown → | 2008 | 1557 |
| 8 | Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials Hit paper breakdown → | 2012 | 1552 |
| 9 | Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin Hit paper breakdown → | 1984 | 1448 |
| 10 | Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro Hit paper breakdown → | 1985 | 1404 |
| 11 | Molecular targets of dietary agents for prevention and therapy of cancer Hit paper breakdown → | 2006 | 1383 |
| 12 | Nuclear factor-κB Hit paper breakdown → | 2004 | 1363 |
| 13 | CURCUMIN: THE INDIAN SOLID GOLD Hit paper breakdown → | 2007 | 1318 |
| 14 | Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) Hit paper breakdown → | 1995 | 1205 |
| 15 | Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Hit paper breakdown → | 2004 | 1178 |
| 16 | Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer Hit paper breakdown → | 2008 | 1071 |
| 17 | Inflammation and cancer: How hot is the link? Hit paper breakdown → | 2006 | 1068 |
| 18 | Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Hit paper breakdown → | 1996 | 1025 |
| 19 | Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature Hit paper breakdown → | 2008 | 995 |
| 20 | Curcumin and cancer: An “old-age” disease with an “age-old” solution Hit paper breakdown → | 2008 | 917 |
About Bharat B. Aggarwal
Bharat B. Aggarwal is a scholar working on Molecular Biology, Cancer Research, Immunology, Molecular Medicine and Oncology, having authored 574 papers that have together received 105.6k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (164 papers), Curcumin's Biomedical Applications (107 papers), Natural product bioactivities and synthesis (88 papers), Immune Response and Inflammation (67 papers), Cytokine Signaling Pathways and Interactions (52 papers), Pharmacological Effects of Medicinal Plants (42 papers), Genomics, phytochemicals, and oxidative stress (36 papers) and Retinoids in leukemia and cellular processes (35 papers). The work is most often cited by research in Molecular Medicine (25.4k citations), Toxicology (3.7k citations), Geriatrics and Gerontology (3.0k citations), Cancer Research (13.2k citations) and Biochemistry (5.4k citations). Bharat B. Aggarwal has collaborated with scholars based in United States, India and Germany. Frequent co-authors include Ajaikumar B. Kunnumakkara, Subash C. Gupta, Shishir Shishodia, Bokyung Sung, Preetha Anand, Sahdeo Prasad, Gautam Sethi, Kuzhuvelil B. Harikumar, Madan M. Chaturvedi and Yasunari Takada. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology, Biochemical Pharmacology, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.